Plus Therapeutics (PSTV) Interest Coverage Ratio (2016 - 2025)
Plus Therapeutics (PSTV) has disclosed Interest Coverage Ratio for 15 consecutive years, with 6.45 as the latest value for Q1 2025.
- On a quarterly basis, Interest Coverage Ratio rose 93.35% to 6.45 in Q1 2025 year-over-year; TTM through Sep 2025 was 22.24, a 66.91% increase, with the full-year FY2024 number at 82.09, down 143.43% from a year prior.
- Interest Coverage Ratio was 6.45 for Q1 2025 at Plus Therapeutics, up from 68.42 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 6.45 in Q1 2025 to a low of 136.93 in Q2 2024.
- A 5-year average of 43.44 and a median of 37.37 in 2023 define the central range for Interest Coverage Ratio.
- Peak YoY movement for Interest Coverage Ratio: tumbled 929.24% in 2024, then skyrocketed 93.35% in 2025.
- Plus Therapeutics' Interest Coverage Ratio stood at 17.5 in 2021, then plummeted by 115.2% to 37.65 in 2022, then decreased by 6.74% to 40.19 in 2023, then tumbled by 70.25% to 68.42 in 2024, then skyrocketed by 90.57% to 6.45 in 2025.
- Per Business Quant, the three most recent readings for PSTV's Interest Coverage Ratio are 6.45 (Q1 2025), 68.42 (Q4 2024), and 62.28 (Q3 2024).